{"result": "(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>Nutritional therapy involving the administration of nutrients directly into the gastrointestinal tract, often through a tube, which can interact with medications.)\n##\n(\"entity\"<|>FÁRMACOS<|>ORGANIZATION<|>Medications that can interact with nutrients, affecting their absorption and efficacy in patients receiving enteral nutrition.)\n##\n(\"entity\"<|>FARMACÉUTICO HOSPITALARIO<|>PERSON<|>A hospital pharmacist who assists in managing drug-nutrient interactions and finding therapeutic alternatives for patients.)\n##\n(\"entity\"<|>MONTORO RONSANO JB<|>PERSON<|>Author of a publication on drug-nutrient interactions, contributing to the understanding of enteral nutrition.)\n##\n(\"entity\"<|>NOVARTIS CONSUMER HEALTH S.A.<|>ORGANIZATION<|>A company that published a book on drug-nutrient interactions, focusing on enteral nutrition.)\n##\n(\"entity\"<|>JCAHO<|>ORGANIZATION<|>Joint Commission on Accreditation of Healthcare Organizations, which sets standards for healthcare quality, including drug-nutrient interactions.)\n##\n(\"relationship\"<|>FÁRMACOS<|>NUTRICIÓN ENTERAL<|>Fármacos can interact with nutrientes in enteral nutrition, affecting patient treatment outcomes<|>8)\n##\n(\"relationship\"<|>FARMACÉUTICO HOSPITALARIO<|>NUTRICIÓN ENTERAL<|>El farmacéutico hospitalario ayuda a gestionar las interacciones entre fármacos y nutrientes en la nutrición enteral<|>7)\n##\n(\"relationship\"<|>MONTORO RONSANO JB<|>FÁRMACOS<|>Montoro Ronsano JB authored a publication discussing drug-nutrient interactions<|>6)\n##\n(\"relationship\"<|>NOVARTIS CONSUMER HEALTH S.A.<|>MONTORO RONSANO JB<|>Novartis published Montoro Ronsano JB's work on drug-nutrient interactions<|>5)\n##\n(\"relationship\"<|>JCAHO<|>FÁRMACOS<|>JCAHO sets standards that include considerations for drug-nutrient interactions in healthcare<|>4)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: no deben\n\nmezclarse y es necesario lavar la sonda con al menos\n10 ml después de cada administración12.\n\nLas propiedades físico-químicas del preparado (pH,\nviscosidad, osmolalidad, presencia de determinados\ncomponentes, como el sorbitol) deben ser cuidadosa-\nmente valoradas cuando se va a administrar a través de\nla sonda. Las formas farmacéuticas cuya osmolaridad\nsea superior a 1.000 mOsm/l pueden producir alteracio-\nnes gastrointestinales, por lo que se deberá diluir el pre-\nparado en mayor volumen de agua (100-150 ml). Los\nmedicamentos que presentan un pH extremo pueden\ninteraccionar con la nutrición enteral. Se debe tener en\ncuenta que el pH en el yeyuno es entre neutro y alcalino,\npor lo que la administración de formas farmacéuticas\nde pH ácido por sonda nasoenteral o yeyunostomía está\nen principio contraindicada, por el riesgo de precipita-\nción por la diferencia de pH. La viscosidad del prepara-\ndo puede dificultar su paso dependiendo de cuál sea el\ndiámetro de la sonda. Como norma, si existe la posibili-\ndad de obstrucción, se deberán extremar los lavados\ntras la administración. Por último, recordar que varias\nformulaciones líquidas contienen sorbitol como exci-\npiente; esta sustancia, en dosis superiores a 10 g diarios,\npuede producir alteraciones gastrointestinales.\n---\nTema 44. Interacción entre dieta y fármacos    715\n\n## 8. Resumen\n\nLas interacciones entre fármacos y nutrientes, por su frecuencia y relevancia clínica, han de ser tenidas en cuenta en la terapéutica nutricional de los pacientes. El farmacéutico hospitalario y/o el farmacólogo pueden ayudarnos a buscar alternativas terapéuticas disponibles en caso de interacción, especialmente en el caso de pacientes que reciben nutrición enteral. Además, existen publicaciones14, 21 y aplicaciones que facilitarán la elección de la formulación terapéutica más apropiada en cada caso.\n\n## 9. Bibliografía\n\n1. Hagan DW, McCabe BJ. Drug–Nutrient Interactions and JCAHO Standards. En: McCabe BJ, Wolfe JJ, Frankel EH, eds. Handbook of food-drug interactions. CRC press, 2003.\n\n2. Montoro Ronsano JB, Suñer Martí P, Salgado Remigio A. Interacciones medicamentos-nutrición enteral. 1era. Edición. Barcelona: Novartis Consumer Health S.A., 2003. http://www.sefh.es/bibliotecavirtual/Monografias/interaccion_medicamento_ne.pdf Acceso 15 de febrero de 2009.\n\n3. Montoro JB, Salgado A. Interacciones fármacos-alimentos. Barcelona: Rubes Editorial, 1999.\n\n4. San Miguel Samano MT, Sánchez Méndez JL. Interacciones alimento/medicamento. Inf Ter Sist Nac Salud 2011; 35: 3-12.\n\n5. Gómez Enterría P. Soporte nutricional. En: Curso de Nutrición Clínica y Dietética en Soporte Digital. Fundación SEEN, 2002.\n\n6. R Lourenço. Enteral Feeding: Drug/nutrient interaction. Clin Nutr 2001, 20: 187-193.\n\n7. Tuneu Valls L, Alba Aranda G. Interacción de fármacos-nutrientes. En: Salas Salvadó J, Bonnada A, Trallero R, Saló ME. Nutrición y dietética clínica. Barcelona: Ediciones Doyma, 2000:529-534.\n\n8. Cardona D. Interacción fármacos-alimentos. Nutr Hosp 1999; 14(s2): 129s-140s.\n\n9. Utermohlen V. Diet, nutrition and drug interactions. En: Shills ME, Olson J A, Shike M, Ross A C (eds) Modern nutrition in health and disease. 9th ed. Baltimore: Williams & Wilkins, 1999: 1619-1641.\n\n10. Florez J, Farmacología humana. 4ª. Ed. Barcelona: Masson, SA, 2004: 1151.\n\n11. MC Vidal Carou, A Mariné Font, T Hernández Jover. Nutrición y tratamientos farmacológicos. Interacciones entre alimentos y medicamentos. En Tratado de Nutrición. M Hernández Rodriguez, A Sastre Gallego, directores. Ediciones Diaz de Santos SA. Madrid 1999: 543-556.\n\n12. Thomson C A, Rollins C J, Nutrient-drug interactions. En: Rombeau J L, Rolandelli R H (eds) Enteral and tube feeding. 3rd ed. Philadelphia: WB Saunders Company, 1997: 523-539.\n\n13. Haken V. Interactions between drugs and nutrients. En: Mahan LK, Escott-Stump S, ed. Krause\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}